MedTrace Logo

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

NCT06812559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-02-25

No results posted yet for this study

Summary

The purpose of this study is to compare the use of the progesterone-primed ovarian stimulation protocol versus GnRH antagonist protocol in women with polycystic ovarian syndrome (PCOS) regarding the number of oocytes retrieved, percentage of MII oocytes, and the rate of good quality blastocysts available for cryopreservation.

Conditions

  • Controlled Ovarian Hyperstimulation
  • Polycystic Ovarian Syndrome

Interventions

DRUG

Progesterone

compare the use of the progesterone-primed ovarian stimulation protocol versus GnRH antagonist protocol in women with polycystic ovarian syndrome (PCOS) regarding the number of oocytes retrieved, percentage of MII oocytes, and the rate of good quality blastocysts available for cryopreservation.

DRUG

GnRH antagonist (Cetrorelix)

Subcutaneous injection

Sponsors & Collaborators

  • El Shatby University Hospital for Obstetrics and Gynecology

    lead OTHER

Principal Investigators

  • Ismail E Khalifa, Ass.lecturer · Elshatby University hospital

  • Sherif S Gafaar, Professor · Elshatby University hospital

Eligibility

Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06812559 on ClinicalTrials.gov